Prof. Jae-Hyung Park and Dong-kyu Cho selected as regular members of KAST
top of page
Core
Technologies
Exosome-based therapeutics
We have various technologies to produce naïve stem cell exosomes and functional exosomes with enhanced therapeutic effects.
앵커 1
Exosome mass production
We have unique technologies "mP³EXO™ platform" for mass-production of exosome therapeutics.
Exosome characterization and R&D capability
We have the specialized R&D organizations and networks to identify the exosome's functions, characteristics and quality.
EXOSTEMTECH PIPELINE
We are developing more than 8 types of therapeutics
by building our own pipeline.
CARTISOME®
Osteoarthritis Treatment
BEIGESOME®
Obesity, Diabetes,
Fatty liver Treatment
EST-T-EXO
Tendinopathy Treatment
OSTEOSOME®
Osteoporosis Treatment
HEPATOSOME®
Liver Fibrosis Treatment
Protein Loading &
Delivery Platform
HYPOXISOME®
Pulmonary Fibrosis Treatment
EST-SFX-T
Anti-cancer Drug
NEWS
News of ExoStemTech that the world is paying attention to
Sustainable Company
Contributing to the Healthy Life of Mankind
based on Innovative Biotechnology
bottom of page